Testing effectiveness (Phase 2)Not Yet RecruitingNCT07299409
What this trial is testing
First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.
Who this might be right for
Advanced Triple Negative Breast CancerBreast Cancer MetastaticBreast Cancer
Nathalie Levasseur 24